Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP22 inhibits AKT. 3 / 4

| 3

➶

reach

"Furthermore, our results showed that USP22 deletion also caused down-regulation of Akt and GSK3beta activity, which can also contribute to the reduction of cyclin D2."

21928107

➶

reach

"Silencing Smad4 blocked USP22 knockdown induced Akt inhibition in Bel/Fu cells."

28445968

➶

reach

"Downregulation of USP22 Inhibited the Activation of PI3K and Akt Signaling Pathway."

27983930

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP22 inhibits AKT. 3 / 4

Our Sources:

Databases

Reading